Regev, Aviv
Genentech, Inc,
United States
2025 Rank: 2,370
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Developmental Biology
SubField 2:
Immunology
Rank in SubField 1: 64 out of 157,999 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 2,370 | 2,492 |
| Total Cites | 19,661 | 20,650 |
| H-index | 71 | 73 |
| Hm-index | 15 | 16 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 9 | 9 |
| Total Cites to Single+First Authored Papers | 210 | 234 |
| Number of Single+First+Last Authored Papers | 109 | 109 |
| Total Cites to Single+First+Last Authored Papers | 5,888 | 6,083 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 14,539 | 14,896 |
| Ratio of Total Citations to Distinct Citing Papers | 1.35 | 1.39 |
| Self-Citation Percentage |
4.79%
|
|
Regev, Aviv
Genentech, Inc,
United States
2024 Rank: 2,305
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Developmental Biology
SubField 2:
Immunology
Rank in SubField 1: 65 out of 149,337 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 2,305 | 2,318 |
| Total Cites | 19,163 | 20,151 |
| H-index | 69 | 72 |
| Hm-index | 15 | 16 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 9 | 9 |
| Total Cites to Single+First Authored Papers | 204 | 223 |
| Number of Single+First+Last Authored Papers | 104 | 104 |
| Total Cites to Single+First+Last Authored Papers | 5,685 | 5,858 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 14,014 | 14,408 |
| Ratio of Total Citations to Distinct Citing Papers | 1.37 | 1.40 |
| Self-Citation Percentage |
4.90%
|
|
Regev, Aviv
Massachusetts Institute of Technology,
United States
2023 Rank: 2,359
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Developmental Biology
SubField 2:
Immunology
Rank in SubField 1: 79 out of 138,178 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 2,359 | 2,460 |
| Total Cites | 19,746 | 20,800 |
| H-index | 69 | 72 |
| Hm-index | 14 | 15 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 8 | 8 |
| Total Cites to Single+First Authored Papers | 241 | 267 |
| Number of Single+First+Last Authored Papers | 99 | 99 |
| Total Cites to Single+First+Last Authored Papers | 5,756 | 5,947 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 14,530 | 14,942 |
| Ratio of Total Citations to Distinct Citing Papers | 1.36 | 1.39 |
| Self-Citation Percentage |
5.07%
|
|
Regev, Aviv
Massachusetts Institute of Technology,
United States
2022 Rank: 2,700
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Developmental Biology
SubField 2:
Immunology
Rank in SubField 1: 100 out of 127,685 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 2,700 | 2,778 |
| Total Cites | 18,309 | 19,281 |
| H-index | 64 | 66 |
| Hm-index | 13 | 14 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 7 | 7 |
| Total Cites to Single+First Authored Papers | 213 | 250 |
| Number of Single+First+Last Authored Papers | 86 | 86 |
| Total Cites to Single+First+Last Authored Papers | 5,181 | 5,368 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 13,586 | 14,007 |
| Ratio of Total Citations to Distinct Citing Papers | 1.35 | 1.38 |
| Self-Citation Percentage |
5.04%
|
|
Regev, Aviv
Massachusetts Institute of Technology,
United States
2021 Rank: 3,917
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Developmental Biology
SubField 2:
Immunology
Rank in SubField 1: 153 out of 123,644 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 3,917 | 4,041 |
| Total Cites | 24,172 | 25,432 |
| H-index | 74 | 78 |
| Hm-index | 14 | 15 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 7 | 7 |
| Total Cites to Single+First Authored Papers | 319 | 379 |
| Number of Single+First+Last Authored Papers | 77 | 77 |
| Total Cites to Single+First+Last Authored Papers | 7,286 | 7,561 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 18,029 | 18,566 |
| Ratio of Total Citations to Distinct Citing Papers | 1.34 | 1.37 |
| Self-Citation Percentage |
4.95%
|
|
Regev, Aviv
Broad Institute,
United States
2020 Rank: 4,735
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Developmental Biology
SubField 2:
Immunology
Rank in SubField 1: 192 out of 105,600 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 4,735 | 4,851 |
| Total Cites | 14,972 | 15,803 |
| H-index | 59 | 60 |
| Hm-index | 12 | 12 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 6 | 6 |
| Total Cites to Single+First Authored Papers | 203 | 250 |
| Number of Single+First+Last Authored Papers | 66 | 66 |
| Total Cites to Single+First+Last Authored Papers | 5,433 | 5,631 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 11,044 | 11,396 |
| Ratio of Total Citations to Distinct Citing Papers | 1.36 | 1.39 |
| Self-Citation Percentage |
5.26%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.